By Notice dated May 5, 2004, and published in the Federal Register on May 26, 2004, (69 FR 29979), Boehringer Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances:
| Drug | Schedule |
|---|---|
| Amphetamine (1100) | II |
| Methylphenidate (1724) | II |
| Methadone (9250) | II |
| Methadone Intermediate (9254) | II |
| Dextropropoxyphene (9273) | II |
| Levo-alphacetylmethadol (9648) | II |
| Fentanyl (9801) | II |
The company plans to manufacture the listed controlled substances for formulation into finished pharmaceuticals.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemicals Inc. to manufacture the basic classes of controlled substances listed is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemicals Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: September 16, 2004,
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 04-21957 Filed 9-29-04; 8:45 am]
BILLING CODE 4410-09-M